What Counts as Emerging Wellness Science?
What we mean by emerging wellness science, how an idea moves from lab to approval, and why a new or popular wellness topic is not the same as a proven one.
Content last updated . This page has not been medically reviewed.
What counts as emerging
On this site, "emerging wellness science" means health and wellness ideas where research is still early, rapidly changing, or far behind public interest. Examples in this section include peptides, longevity compounds and biohacking tools. An idea can be emerging because it is new, or because it is old but newly popular and only recently studied. "Emerging" does not mean promising, proven or safe. It is a description of how much is known so far. This definition is how we use the term, not a regulator's.How an idea normally moves forward
For medicines, the FDA describes a path. Researchers identify a candidate, and thousands of compounds may start, but after early testing only a small number look promising. [1] Next comes preclinical work in cells and animals to check for serious harm before people are involved. [2] Then clinical research in people begins with small Phase 1 studies of about 20 to 100 participants, followed by larger studies. [3] Finally, a developer can apply for approval, and the FDA review team examines all the data. [4]Many wellness topics sit at the first or second step but are discussed as if they were at the last. Our pages say where a topic stands.
Approved, investigational and marketed are different
- Approved medicine: reviewed and approved by a regulator for a named use. [4]
- Investigational: still being tested in studies. It is not an endorsement.
- Sold as a supplement or wellness product: the FDA says it does not have the authority to approve dietary supplements before they are marketed. [5]
The NCCIH adds that the FDA is not authorized to review dietary supplements for safety and effectiveness before they are marketed. [6] So availability for sale tells you little about how well a product has been studied.
Popular is not the same as proven
Highly cited and widely shared studies can be overturned. In a review of 49 highly cited clinical studies, 16% were later contradicted and another 16% had found stronger effects than later research. [7] That is a reason to wait for repeated, well-designed human studies before treating a topic as settled.How to approach emerging topics
- Read what stage the evidence is at, using our evidence labels.
- Learn to judge studies with reading early-stage research.
- Check a regulator's page and how supplements are regulated.
- Talk with a clinician or pharmacist, especially if you take medicines, are pregnant, or have a health condition.
Return to the Emerging Wellness Science overview.
Frequently asked questions
Is emerging wellness science the same as experimental or unproven?
Often overlapping, but not identical. We use "emerging" for topics where research is still early or changing. Each page names the evidence level for specific claims.
Does being sold in stores mean a supplement was studied?
No. The FDA does not approve dietary supplements before they are marketed. [5]
Do most promising lab findings become treatments?
No. The FDA says only a small number of compounds look promising after early testing. [1]
Should I wait for more research before trying something new?
That is a personal decision to make with a clinician. Early evidence cannot tell us whether something helps or harms, so ask a professional who knows your health and medicines.
References
- U.S. Food and Drug Administration. Step 1: Discovery and Development. Read 2026-10-22.
- U.S. Food and Drug Administration. Step 2: Preclinical Research. Read 2026-10-22.
- U.S. Food and Drug Administration. Step 3: Clinical Research. Read 2026-10-22.
- U.S. Food and Drug Administration. Step 4: FDA Drug Review. Read 2026-10-22.
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements. Read 2026-10-22.
- National Center for Complementary and Integrative Health (NIH). Using Dietary Supplements Wisely. Read 2026-10-22.
- Ioannidis JPA. Contradicted and initially stronger effects in highly cited clinical research. JAMA. 2005. PMID 16014596. Read 2026-10-22.